Discovery of a potent FKBP38 agonist that ameliorates HFD-induced hyperlipidemia via mTOR/P70S6K/SREBPs pathway

Publication date: Available online 22 March 2021Source: Acta Pharmaceutica Sinica BAuthor(s): Ping-Ting Xiao, Zhi-Shen Xie, Yu-Jia Kuang, Shi-Yu Liu, Chun Zeng, Ping Li, E-Hu Liu

Source: Acta Pharmaceutica Sinica B - March 22, 2021 Category: Cancer & Oncology Source Type: research